Adial Pharmaceuticals (NASDAQ:ADIL – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.59) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.39) by ($0.20), Zacks reports.
Adial Pharmaceuticals Price Performance
Adial Pharmaceuticals stock traded up $0.00 during trading hours on Thursday, reaching $0.97. The company had a trading volume of 166,381 shares, compared to its average volume of 3,723,688. Adial Pharmaceuticals has a 12-month low of $0.77 and a 12-month high of $4.46. The company has a 50-day moving average price of $1.12 and a 200 day moving average price of $1.40.
About Adial Pharmaceuticals
Featured Articles
- Five stocks we like better than Adial Pharmaceuticals
- Why Are Stock Sectors Important to Successful Investing?
- Michael Burry’s Alibaba Bet and the Broader Market Implications
- Find and Profitably Trade Stocks at 52-Week Lows
- Jeff Brown’s Exegesis AI Stock Picks
- How to Evaluate a Stock Before Buying
- Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock
Receive News & Ratings for Adial Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adial Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.